Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy

Diabetes Care

Volumn 20, Issue 10, 1997, Pages 1594-1597

  Oskarsson, Per ^a   Ljunggren, Jan Gustaf ^b   Lins, Per Eric ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MEXILETINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; TACHYCARDIA;

EID: 0030798224     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.10.1594     Document Type: Article

References (14)

1. Ward JD: Diabetic neuropathy. Br Med Bull 45:111-126, 1989
2. Wright JM: Review of the symptomatic treatment of diabetic neuropathy. Pharmacotherapy 14:689-697, 1994
3. Calissi PT, Jaber LA: Peripheral diabetic neuropathy: current concepts in treatment. Ann Pharmacother 29:769-777, 1995
4. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes O: Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo Study. Br Med J 293: 1195-1199, 1986
5. Sindrup SH, Ejlertsen B, Froland A, Sindrup EH, Brosen K, Gram LF: Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. Eur J Clin Pharmacol 37:151-153, 1989
6. Max MB, Lynch SA, Muir J, Shoaf SA, Smoller B, Dubner R: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256, 1992
7. Gomez-Perez FJ, Rull JA, Dies H, Rodriquez-Rivera JG, Gonzalez-Barranco J, Lozano-Castaneda O: Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: a double-blind cross-over study. Pain 23:395-400, 1985
8. Wilton TD: Tegretol in the treatment of diabetic neuropathy. S Afr Med J 48:869-872, 1974
9. Saudek CD, Werns S, Reidenberg MM: Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 22:196-199, 1977
10. The Capsaicin Study Group: Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 151:2225-2229, 1991
11. Kastrup J, Angelo H, Petersen P, Dejgard A, Hilsted J: Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion. Br Med J 292:173, 1986
12. Dejgard A, Petersen P, Kastrup J: Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet i:8575-8576, 1988
13. Stracke H, Meyer UE, Schumacher HE, Federlin K: Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 15:1550-1555, 1992
14. Monk JP, Brogden RN: Mexiletine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs 40:374-411, 1990 (Erratum. Drugs 41:377, 1991)